Research Progress of Ovarian Tissue Cryopreservation and Transplantation
DOI:
https://doi.org/10.53469/wjimt.2024.07(05).19Keywords:
Ovarian tissue cryopreservation, Ovarian tissue transplantation, Follicle lossAbstract
Age, disease and anti-tumor treatment may cause the decline or even loss of female fertility. Embryo cryopreservation, oocyte cryopreservation and ovarian tissue cryopreservation are commonly used at present. Cryopreservation and transplantation of ovarian tissue has become a fertility preservation method with medical indications in clinic, which is helpful for patients to successfully complete fertility through this technology. This paper reviews the international research progress on ovarian cryopreservation and transplantation in recent years. Despite the rapid development of ovarian tissue cryopreservation and transplantation technology, it still faces challenges such as how to reduce the loss of follicular reserve and thus prolong the effectiveness of ovarian tissue transplantation. More basic and clinical research is needed to promote the progress and development of ovarian tissue cryopreservation and transplantation technology.
References
Mercier, A.; Johnson, J.; Kallen, A. N. (2024). Prospective solutions to ovarian reserve damage during the ovarian tissue cryopreservation and transplantation procedure. Fertil Steril 122, 565-573.
Li, Z.; Qi, H.; Li, Z.; Bao, Y.; Yang, K.; Min, Q. (2023). Research progress on the premature ovarian failure caused by cisplatin therapy. Front Oncol 13, 1276310.
Pascuali, N.; Scotti, L.; Di Pietro, M.; Oubina, G.; Bas, D.; May, M.; Gomez Munoz, A.; Cuasnicu, P. S.; Cohen, D. J.; Tesone, M.; Abramovich, D.; Parborell, F. (2018). Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure. Hum Reprod 33, 844-859.
Xiao, S.; Zhang, J.; Romero, M. M.; Smith, K. N.; Shea, L. D.; Woodruff, T. K. (2015). In vitro follicle growth supports human oocyte meiotic maturation. Sci Rep 5, 17323.
Casciani, V.; Monseur, B.; Cimadomo, D.; Alvero, R.; Rienzi, L. (2023). Oocyte and embryo cryopreservation in assisted reproductive technology: past achievements and current challenges. Fertil Steril 120, 506-520.
Yang, Q.; Zhu, L.; Jin, L. (2020). Human Follicle in vitro Culture Including Activation, Growth, and Maturation: A Review of Research Progress. Front Endocrinol (Lausanne) 11, 548.
Ho, V. N. A.; Braam, S. C.; Pham, T. D.; Mol, B. W.; Vuong, L. N. (2019). The effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilization in women with a high antral follicle count. Human Reproduction 34, 1055-1064.
MAZUR, P. (1963). KINETICS OF WATER LOSS FROM CELLS AT SUBZERO TEMPERATURES AND THE LIKELIHOOD OF INTRACELLULAR FREEZING. J Gen Physiol, 347-69.
D. G. Whittingham, S. P. L., and P. Mazur (1972). Survival of Mouse Embryos Frozen to -196° and -269°C. Science 178(4059), 411-4.
Donnez J, D. M., Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B, van Langendonckt A (2004). Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364(9443):, 1405-10..
Donnez, J.; Dolmans, M. M.; Demylle, D.; Jadoul, P.; Pirard, C.; Squifflet, J.; Martinez-Madrid, B.; van Langendonckt, A. (2004). Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364, 1405-10.
Hovatta O, S. R., Krausz T, Abir R, Margara R, Trew G, Lass A, Winston RM. (1996). Cryopreservation of human ovarian tissue using dimethylsulphoxide and propanediol-sucrose as cryoprotectants. Hum Reprod 11(6), 1268-72.
Kuleshova L, G. L., Magli C, Ferraretti A, Trounson A. (1999 Dec). Birth following vitrification of a small number of human oocytes: case report. Hum Reprod 14(12), 3077-9.
Jakimiuk, A. J.; Grzybowski, W. (2007). Ovarian tissue preservation, present and clinical perspectives. Gynecol Endocrinol 23, 87-93.
Salama, M.; Woodruff, T. K. (2015). New advances in ovarian autotransplantation to restore fertility in cancer patients. Cancer Metastasis Rev 34, 807-822.
Dittrich, R.; Lotz, L.; Keck, G.; Hoffmann, I.; Mueller, A.; Beckmann, M. W.; van der Ven, H.; Montag, M. (2012). Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril 97, 387-90.
Beckmann, M. W.; Dittrich, R.; Lotz, L.; van der Ven, K.; van der Ven, H. H.; Liebenthron, J.; Korell, M.; Frambach, T.; Sutterlin, M.; Schwab, R.; Seitz, S.; Muller, A.; von Wolff, M.; Haberlin, F.; Henes, M.; Winkler-Crepaz, K.; Krussel, J. S.; Germeyer, A.; Toth, B. (2018). Fertility protection: complications of surgery and results of removal and transplantation of ovarian tissue. Reprod Biomed Online 36, 188-196.
Beckmann, M. W.; Dittrich, R.; Lotz, L.; Oppelt, P. G.; Findeklee, S.; Hildebrandt, T.; Heusinger, K.; Cupisti, S.; Muller, A. (2017). Operative techniques and complications of extraction and transplantation of ovarian tissue: the Erlangen experience. Arch Gynecol Obstet 295, 1033-1039.
Feng, X.; Ling, L.; Zhang, W.; Liu, X.; Wang, Y.; Luo, Y.; Xiong, Z. (2020). Effects of Human Amnion-Derived Mesenchymal Stem Cell (hAD-MSC) Transplantation In Situ on Primary Ovarian Insufficiency in SD Rats. Reprod Sci 27, 1502-1512.
Xie, B.; Li, J.; Huang, Y.; Hang, F.; Hu, Q.; Yu, J.; Qin, A. (2023). Assessing the impact of transplant site on ovarian tissue transplantation: a single-arm meta-analysis. Reprod Biol Endocrinol 21, 120.
Oktay, K. H.; Marin, L. (2024). Comparison of orthotopic and heterotopic autologous ovarian tissue transplantation outcomes. Fertil Steril 121, 72-79.
Dolmans, M. M.; Donnez, J.; Cacciottola, L. (2021). Fertility Preservation: The Challenge of Freezing and Transplanting Ovarian Tissue. Trends Mol Med 27, 777-791.
Brouillet, S.; Ferrieres-Hoa, A.; Fournier, A.; Martinez, G.; Bessonnat, J.; Gueniffey, A.; Gala, A.; Loup, V.; Hamamah, S. (2020). Cryopreservation of Oocytes Retrieved from Ovarian Tissue to Optimize Fertility Preservation in Prepubertal Girls and Women. J Vis Exp.
Filippi, F.; Meazza, C.; Paffoni, A.; Raspagliesi, F.; Terenziani, M.; Somigliana, E. (2016). Egg Freezing in Childhood and Young Adult Cancer Survivors. Pediatrics 138.
Ruan, X. (2018). Chinese Society of Gynecological Endocrinology affiliated to the International Society of Gynecological Endocrinology Guideline for Ovarian Tissue Cryopreservation and Transplantation. Gynecol Endocrinol 34, 1005-1010.
Schleedoorn, M. J.; Mulder, B. H.; Braat, D. D. M.; Beerendonk, C. C. M.; Peek, R.; Nelen, W.; Van Leeuwen, E.; Van der Velden, A.; Fleischer, K.; Turner Fertility Expert Panel, O. (2020). International consensus: ovarian tissue cryopreservation in young Turner syndrome patients: outcomes of an ethical Delphi study including 55 experts from 16 different countries. Hum Reprod 35, 1061-1072.
Celik, S.; Ozkavukcu, S.; Celik-Ozenci, C. (2023). Recombinant anti-Mullerian hormone treatment attenuates primordial follicle loss after ovarian cryopreservation and transplantation. Journal of Assisted Reproduction and Genetics 40, 1117-1134.
Celik, S.; Ozkavukcu, S.; Celik-Ozenci, C. (2020). Altered expression of activator proteins that control follicle reserve after ovarian tissue cryopreservation/transplantation and primordial follicle loss prevention by rapamycin. Journal of Assisted Reproduction and Genetics 37, 2119-2136.
Lornage J, S. B. (2007 Aug;). Ovarian and oocyte cryopreservation. Curr Opin Obstet Gynecol. 19(4):, 390-4..
Zhang, M.; Gao, J.; Huang, Y.; Li, M.; Zhao, H.; Zhao, Y.; Li, R.; Yan, J.; Yu, Y.; Qiao, J. (2015). Effect of Local Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor on Subcutaneously Allotransplanted Ovarian Tissue in Ovariectomized Mice. Plos One 10.
Kolusari, A.; Okyay, A. G.; Kockaya, E. A. (2018). The Effect of Erythropoietin in Preventing Ischemia-Reperfusion Injury in Ovarian Tissue Transplantation. Reprod Sci 25, 406-413.
Tanaka, A.; Nakamura, H.; Tabata, Y.; Fujimori, Y.; Kumasawa, K.; Kimura, T. (2018). Effect of sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogels on frozen-thawed human ovarian tissue in a xenograft model. J Obstet Gynaecol Res 44, 1947-1955.
Tsai, Y. C.; Tzeng, C. R.; Wang, C. W.; Hsu, M. I.; Tan, S. J.; Chen, C. H. (2014). Antiapoptotic agent sphingosine-1-phosphate protects vitrified murine ovarian grafts. Reprod Sci 21, 236-43.
Fransolet, M.; Noel, L.; Henry, L.; Labied, S.; Blacher, S.; Nisolle, M.; Munaut, C. (2019). Evaluation of Z-VAD-FMK as an anti-apoptotic drug to prevent granulosa cell apoptosis and follicular death after human ovarian tissue transplantation. J Assist Reprod Genet 36, 349-359.
Manavella, D. D.; Cacciottola, L.; Payen, V. L.; Amorim, C. A.; Donnez, J.; Dolmans, M. M. (2019). Adipose tissue-derived stem cells boost vascularization in grafted ovarian tissue by growth factor secretion and differentiation into endothelial cell lineages. Mol Hum Reprod 25, 184-193.